New Delhi: India saw foreign direct investment (FDI) of $341.49 million in the drugs and pharmaceuticals sector between April 2009 and February 2012, the Government said on Monday.
At present, the Government allows 100 per cent FDI for both greenfield and existing projects in these sectors, the Minister of State for Commerce and Industry, Mr Jyotiraditya Scindia, said in a written reply in the Rajya Sabha on Monday.
However, the Ministry had not maintained a comprehensive data with regard to acquisition of pharmaceutical companies by multinational players, he added.
Mr Scindia said there was no proposal to make policy changes with regard to FDI in oil and gas exploration, petroleum refining, micro, small and medium enterprises.
Policy changes related to FDI are reviewed continuously to make it more investor friendly, he added.
The Government had liberalised investments made by registered foreign institutional investors (FIIs) under the Portfolio Investment Scheme (PIS) from April 10, 2012. Earlier, these investments required Government approval.
"Believer - Humanitarian - Habit of Success" Sukumar Balakrishnan is the Founder of JB GROUP, a 500 Crore National Organization with over 150 Direct & 1200 indirect professionals operating from 5 major cities in India. Jayalakshmi Balakrishnan Group, a multi-faceted group venturing into, E- Commerce and Import-Export (INNOKAIZ), Retail and Wholesale (JB MART), Food and Beverages (KRISHNA FOODS ), Real Estate (Constructions on sites, Interior scaping, Facility Management)
Total Pageviews
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment